| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0042 | 1 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |